This document provides the 2011 update to the AHA/ACCF guidelines for secondary prevention and risk reduction therapy in patients with coronary and other atherosclerotic vascular disease.
The American Heart Association makes every effort to avoid any actual or potential conflicts of interest that may arise as a result of an outside relationship
Smith et al. (2011) studied this question.